(Q40652799)

22 September 2017

title

Evaluation of eicosanoids and NSAIDs as PPARgamma ligands in colorectal carcinoma cells (English)

1 reference

22 September 2017

1 reference

3

1 reference

22 September 2017

Nixon JB

1

1 reference

22 September 2017

Kamitani H

series ordinal

2

1 reference

22 September 2017

Eling TE

series ordinal

4

1 reference

22 September 2017

publication date

1 May 2003

1 reference

Prostaglandins, Leukotrienes and Essential Fatty Acids

22 September 2017

published in

1 reference

22 September 2017

volume

68

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

323-330

1 reference

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Cyclooxygenase, NSAIDs, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

COX-2: a target for colon cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900023-1

7 January 2021

10.1016/S0952-3278(03)00023-1

Identifiers

DOI

1 reference

22 September 2017

1 reference